---
title: "SC Pharmaceuticals fell over 6% and again warned of potential *ST status"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/229698783.md"
description: "SC Pharmaceuticals fell over 6% to HKD 14.6, with a total market value of HKD 6.18 billion. The company announced after the market closed yesterday that, according to preliminary calculations by the finance department, it expects a net profit attributable to shareholders of the listed company to be negative for the fiscal year 2024, and the operating revenue after deductions to be below HKD 300 million. According to the relevant provisions of the Shenzhen Stock Exchange's listing rules, the company's stock trading may be subject to delisting risk warnings after the disclosure of the 2024 annual report. This is the second risk warning regarding the potential delisting risk for the company's stock trading"
datetime: "2025-02-26T06:25:12.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/229698783.md)
  - [en](https://longbridge.com/en/news/229698783.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/229698783.md)
---

# SC Pharmaceuticals fell over 6% and again warned of potential *ST status

SC Pharmaceuticals fell over 6% to HKD 14.6, with a total market value of HKD 6.18 billion. The company announced after the market closed yesterday that, according to preliminary calculations by the finance department, it expects a net profit attributable to shareholders of the listed company to be negative for the fiscal year 2024, and the operating revenue after deductions to be below HKD 300 million. In accordance with the relevant provisions of the Shenzhen Stock Exchange's listing rules, the company's stock trading may be subject to delisting risk warnings after the disclosure of the 2024 annual report. This is the second risk warning regarding the potential delisting risk for the company's stock trading

### Related Stocks

- [002693.CN](https://longbridge.com/en/quote/002693.CN.md)

## Related News & Research

- [Nvidia's next moat is something chip rivals can't copy: its giant pile of money](https://longbridge.com/en/news/295638789.md)
- [EM investment flows turn positive as equity exodus slowed, IIF says](https://longbridge.com/en/news/295540878.md)
- [FDA Issues Warning About Certain Products Containing Toxic Yellow Oleander](https://longbridge.com/en/news/295690341.md)
- [Opus One Gold rolls out 10% omnibus equity incentive plan for share-based awards](https://longbridge.com/en/news/295700055.md)
- [15:03 ETMNA: MGB Refuses to Schedule More Negotiations or Make Any Proposals to Brigham Nurses in Third Session Following Historic Strike](https://longbridge.com/en/news/295569711.md)